Both in Pharmaceuticals
ZOETIS vs Roivant Sciences
Over the past year ZTS returned −50.9% and ROIV returned +141.7%; their daily moves had a correlation of 0.00.
ZTS −50.9% ROIV +141.7%Growth of $1, one year, split-adjusted
| Metric | ZTS | ROIV |
|---|---|---|
| Price | $70.30 | $36.50 |
| Market cap | $29.05B | $26.36B |
| Today | −1.58% | −1.30% |
| 1 month | −9.1% | +5.2% |
| 6 months | −39.6% | +38.2% |
| Year to date | −44.1% | +68.2% |
| 1 year | −51.0% | +140.6% |
| Revenue growth (YoY) | −0.2% | −33.5% |
| Gross margin | 72.7% | 100.0% |
| Net margin | 28.0% | −13164.8% |
| P/E (TTM) | 11.1× | — |
| Price / sales | 3.1× | 3,500.4× |
| Net cash | -$7.37B | $3.84B |
| Dividend yield | 3.02% | — |
| Volatility (60d) | 30.1% | 49.4% |
| Short % of float | 4.7% | 9.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).